Brought to you by 
Aquinox closes $14.5mm Series A financing
14 Sep 2020
Executive Summary
Aquinox Pharmaceuticals Inc. (small-molecule cancer, autoimmune, and inflammation therapeutics) raised $14.5mm through its Series A financing that was led by Ventures West Capital. New investors Johnson & Johnson Development Corp. and Baker Brothers Investments were joined by returning buyer BC Advantage Funds (managed by Lions Capital).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aquinox closes $14.5mm Series A financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice